J. Anim Sci.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J. Anim Sci. 1987. 65:1292-1297.
© 1987 American Society of Animal Science

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, A. L.
Right arrow Articles by Becker, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, A. L.
Right arrow Articles by Becker, S. E.

Effects of Physiologic and Pharmacologic Agents on Serum Prolactin Concentrations in the Nonpregnant Mare1,2,

A. L. Johnson and S. E. Becker

Rutgers University3, New Brunswick, NJ 08903

Abstract

Four studies were conducted to evaluate the effects of several physiologic and pharmacologic agents on serum prolactin concentrations in the nonpregnant mare. An increase in prolactin measured in response to administration of thyrotropin-releasing hormone (TRH; 50 µg, iv) was found not to vary (P=.20) in mares in estrus compared with mares in diestrus (5 to 10 d post-ovulation). Administration in the dopamine receptor blocker, metoclopramide (25 or 100 mg, im), rapidly increased serum prolactin, and the response was dependent on dose administered (total prolactin measured for 420 min was 3,362.7 ± 182.1 ng for 25 mg, and 4,485.7 ± 212.6 ng for 100 mg administered im; P<.05), but not on route of injection (3,026.3 ± 492.3 ng prolactin with 25 mg, iv; P<.05). Similarly, sulpiride, a D-2 dopamine receptor blocker, induced an increase in serum prolactin, which appeared to be maximal at a dose of 25 mg (6,556.3 ± 636.9 ng prolactin/420 min compared with 6,594.5 ± 169.3 ng prolactin/420 min with 100 mg sulpiride; P>.10). Finally, bromocriptine, a dopamine agonist, decreased serum prolactin compared with vehicle-injected controls, but the inhibitory effect was found only when basal levels of serum prolactin were highest (in May). These data suggest that mechanisms controlling prolactin secretion in the mare are similar to those described in other mammalian species, and that the seasonal decline in serum prolactin is not the result of increased sensitivity to the proposed prolactin-inhibiting factor, dopamine.


Footnotes

1 Publication D-06106-01-87 of the New Jersey Agric. Exp. Sta.

2 The authors thank Ms. C. Brown and D. Richard for excellent technical assistance and Ms. C. J. Uckele for typing the manuscript.

3 Dept. Anim. Sci.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by the American Society of Animal Science.